Sharps Technology (STSS) Competitors $9.12 -0.18 (-1.94%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$9.25 +0.13 (+1.43%) As of 09/12/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock STSS vs. TMDIF, ECOR, RBOT, POCI, CLGN, STRR, VVOS, COCH, NRXS, and RVPShould you be buying Sharps Technology stock or one of its competitors? The main competitors of Sharps Technology include Titan Medical (TMDIF), electroCore (ECOR), Vicarious Surgical (RBOT), Precision Optics (POCI), CollPlant Biotechnologies (CLGN), Hudson Global (STRR), Vivos Therapeutics (VVOS), Envoy Medical (COCH), NeurAxis (NRXS), and Retractable Technologies (RVP). These companies are all part of the "medical equipment" industry. Sharps Technology vs. Its Competitors Titan Medical electroCore Vicarious Surgical Precision Optics CollPlant Biotechnologies Hudson Global Vivos Therapeutics Envoy Medical NeurAxis Retractable Technologies Sharps Technology (NASDAQ:STSS) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, risk, institutional ownership, profitability, valuation and earnings. Which has more volatility and risk, STSS or TMDIF? Sharps Technology has a beta of 2.28, suggesting that its stock price is 128% more volatile than the S&P 500. Comparatively, Titan Medical has a beta of 1.26, suggesting that its stock price is 26% more volatile than the S&P 500. Which has better earnings and valuation, STSS or TMDIF? Titan Medical has higher revenue and earnings than Sharps Technology. Sharps Technology is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSharps TechnologyN/AN/A-$9.30M-$1.21 thousand-0.01Titan Medical$17.63M2.34$6.95M$0.057.24 Does the media prefer STSS or TMDIF? In the previous week, Sharps Technology had 5 more articles in the media than Titan Medical. MarketBeat recorded 5 mentions for Sharps Technology and 0 mentions for Titan Medical. Sharps Technology's average media sentiment score of 0.40 beat Titan Medical's score of 0.00 indicating that Sharps Technology is being referred to more favorably in the media. Company Overall Sentiment Sharps Technology Neutral Titan Medical Neutral Is STSS or TMDIF more profitable? Sharps Technology's return on equity of -8.72% beat Titan Medical's return on equity.Company Net Margins Return on Equity Return on Assets Sharps TechnologyN/A -8.72% -5.30% Titan Medical N/A -82.31%-51.47% Do institutionals and insiders have more ownership in STSS or TMDIF? 17.2% of Sharps Technology shares are held by institutional investors. Comparatively, 0.0% of Titan Medical shares are held by institutional investors. 0.2% of Sharps Technology shares are held by insiders. Comparatively, 0.0% of Titan Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummarySharps Technology beats Titan Medical on 7 of the 10 factors compared between the two stocks. Get Sharps Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for STSS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding STSS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STSS vs. The Competition Export to ExcelMetricSharps TechnologyMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$234.18M$10.63B$5.82B$10.13BDividend YieldN/A1.84%5.68%4.59%P/E RatioN/A21.5175.4125.98Price / SalesN/A38.77514.80293.17Price / CashN/A24.8137.5660.44Price / Book0.083.5212.156.29Net Income-$9.30M$210.50M$3.29B$271.07M7 Day Performance-15.08%-0.18%0.74%3.87%1 Month Performance78.13%2.04%5.00%5.49%1 Year PerformanceN/A-10.98%62.55%25.86% Sharps Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STSSSharps Technology0.7526 of 5 stars$9.12-1.9%N/AN/A$234.18MN/A-0.013Short Interest ↑Gap DownTMDIFTitan MedicalN/A$0.34+2.7%N/A+990.4%$38.38M$17.63M-0.2750ECORelectroCore2.0946 of 5 stars$4.94+0.3%$25.50+416.7%-22.3%$37.41M$25.18M-3.0550RBOTVicarious Surgical1.7168 of 5 stars$6.13-1.7%$7.00+14.3%+2.5%$36.50MN/A-0.61210Analyst UpgradePOCIPrecision Optics0.8065 of 5 stars$4.47-0.3%N/A-18.3%$34.41M$17.63M-5.0480Positive NewsGap DownCLGNCollPlant Biotechnologies3.0724 of 5 stars$2.62-0.8%$11.50+339.1%-45.3%$33.31M$510K-2.3270Short Interest ↓STRRHudson Global1.0793 of 5 stars$9.39-2.5%$5.00-46.8%+127.4%$30.38M$137.86M-7.221,300Gap UpVVOSVivos Therapeutics2.8127 of 5 stars$3.91+2.1%$4.92+25.7%+17.6%$29.33M$15.03M-2.33160Positive NewsAnalyst ForecastShort Interest ↓COCHEnvoy Medical2.1009 of 5 stars$1.30-0.8%$9.25+611.5%-60.5%$27.87M$220K-0.9134Short Interest ↑Gap DownNRXSNeurAxis2.2417 of 5 stars$2.43+0.2%$7.00+188.7%-18.4%$24.04M$3.22M-1.3219Positive NewsShort Interest ↑RVPRetractable Technologies1.2294 of 5 stars$0.80-0.1%N/A-9.7%$23.80M$38.16M-1.47240Short Interest ↑ Related Companies and Tools Related Companies Titan Medical Competitors electroCore Competitors Vicarious Surgical Competitors Precision Optics Competitors CollPlant Biotechnologies Competitors Hudson Global Competitors Vivos Therapeutics Competitors Envoy Medical Competitors NeurAxis Competitors Retractable Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:STSS) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s right about Epstein.A crisis that could devastate your wealth, upend the dollar, and accelerate the collapse of America’s economy....Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredThe Obscure Korean War Act That Created a $5.39 Billion Passive Income StreamAn obscure Korean War law has just been enacted by the U.S. government... Allowing it to take a heavy hand ...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sharps Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sharps Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
